EUVIMEDEUVIMED entdecken
Crossref

Integrated Genomic DNA/RNA Profiling vs Fluorescence in Situ Hybridization in the Detection of MYC and BCL2 (and BCL6 ) Rearrangements in Large B-Cell Lymphomas: Updates Amid the New WHO Classification of Lymphoid Neoplasms

Luiz Paulo de Lima Guido iD, Jennifer Chapman, Daniel P Cassidy

American Journal of Clinical Pathology · 2023

DOI: 10.1093/ajcp/aqad006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Luiz Paulo de Lima Guido und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Jackson Memorial Hospital, Miami, FL, US. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Large B-cell lymphomas (LBCLs) are a heterogeneous group of lymphoid neoplasms whose molecular and cytogenetic profile has predictive and prognostic implications. The concept of double-hit lymphomas (DHLs) was recently updated in the fifth edition of the World Health Organization classification, with the exclusion of MYC and BCL6 rearranged tumors from the group. Now, DHLs are referred to as diffuse large B-cell lymphoma/high-grade B-cell lymphoma with MYC and BCL2 rearrangements. Fluorescence in situ hybridization (FISH) is the current gold standard for detecting rearrangements in LBCLs, but comprehensive genomic profiling (CGP) has recently been suggested to be at least as accurate as FISH in classifying these neoplasms and providing additional genetic information.

Methods

We analyzed a cohort of 131 patients in whom FISH and CGP studies were performed as part of our normal clinical workflow and compared the effectiveness of FISH and CGP in detecting these clinically relevant rearrangements.

Results

Our findings are in agreement with our previously published study, which analyzed a cohort of 69 patients, supporting our hypothesis that the best approach to maximize detection of DHLs while limiting waste seems to be a combination of CGP and MYC break-apart FISH testing, the latter to capture the presence of non–IGH::MYC events.

Conclusions

Our study supports the combined use of FISH and GCP rather than either method alone to better detect MYC and BCL2 (and BCL6) gene rearrangements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycLymphoma, Large B-Cell, DiffuseHumansIn Situ Hybridization, FluorescenceProto-Oncogene Proteins c-bcl-6Proto-Oncogene Proteins c-bcl-2Gene RearrangementGenomics

Stichwörter der Autor:innen

Comprehensive genomic profilingDiffuse large B-cell lymphomaDouble-hit lymphomaFluorescence in situ hybridizationHigh-grade B-cell lymphomaLarge B-cell lymphoma

Substanzen

Proto-Oncogene Proteins c-bcl-6Proto-Oncogene Proteins c-mycProto-Oncogene Proteins c-bcl-2BCL6 protein, humanBCL2 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Jackson Memorial Hospital, Miami, FL, US.
  • Department of Pathology and Laboratory Medicine, University of Miami, Miami, FL, US.

ORCID-Profile: Luiz Paulo de Lima Guido

Zitieren

APA

de Lima Guido, L. P., Chapman, J., & Cassidy, D. P. (2023). Integrated Genomic DNA/RNA Profiling vs Fluorescence in Situ Hybridization in the Detection of MYC and BCL2 (and BCL6 ) Rearrangements in Large B-Cell Lymphomas: Updates Amid the New WHO Classification of Lymphoid Neoplasms. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad006

Vancouver

de Lima Guido LP, Chapman J, Cassidy DP. Integrated Genomic DNA/RNA Profiling vs Fluorescence in Situ Hybridization in the Detection of MYC and BCL2 (and BCL6 ) Rearrangements in Large B-Cell Lymphomas: Updates Amid the New WHO Classification of Lymphoid Neoplasms. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqad006

BibTeX
@article{deLimaGuido2023,
  author = {de Lima Guido, Luiz Paulo and Chapman, Jennifer and Cassidy, Daniel P},
  title = {Integrated Genomic DNA/RNA Profiling vs Fluorescence in Situ Hybridization in the Detection of MYC and BCL2 (and BCL6 ) Rearrangements in Large B-Cell Lymphomas: Updates Amid the New WHO Classification of Lymphoid Neoplasms},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  doi = {10.1093/ajcp/aqad006}
}
Kostenlos starten →